Clinical characteristics, treatment and ocular complications of HLA-B27-related anterior uveitis and HLA-B27-non related anterior uveitis

Reumatol Clin. 2016 Sep-Oct;12(5):244-7. doi: 10.1016/j.reuma.2015.11.008. Epub 2015 Dec 18.
[Article in English, Spanish]

Abstract

Introduction: Anterior uveitis is the most common type of intraocular inflammation. Those associated to HLA-B27 represent 18 to 32% of all anterior uveitis cases.

Objectives: To describe clinical characteristics, systemic treatment need, and frequency and type of ocular complications in a cohort of patients diagnosed with HLAB27-related anterior uveitis and in a cohort of patients diagnosed with HLA-B27 non-related anterior uveitis. To establish if statistically significant differences between both cohorts exist.

Material and methods: We performed a retrospective cohort study including patients with non infectious anterior uveitis related and not related to the antigen HLA-B27.

Results: 162 patients were included, 58 diagnosed with HLA-B27-related anterior uveitis (cohort HLA-B27+1) and 104 diagnosed with HLA-B27- non related anterior uveitis (cohort HLA-B27-). No statistically significant differences were found regarding clinical characteristics between both cohorts with the exception of a higher frequency of recurrences in cohort HLA-B27+ and a higher frequency of chronic uveitis in cohort HLA-B27-. No differences were found regarding systemic treatment use nor development of ocular complications.

Discussion: In contrast to previous studies, we neither found higher male gender predominance in the cohort of patients with HLA-B27-related anterior uveitis, Nor did we find differences regarding average age, laterality, development of complications nor use of systemic corticosteroids.

Keywords: Anterior uveitis; Complicaciones oculares; HLA-B27; Ocular complications; Uveítis anterior.

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Biomarkers / metabolism
  • Case-Control Studies
  • Chronic Disease
  • Female
  • Follow-Up Studies
  • HLA-B27 Antigen / metabolism*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Middle Aged
  • Recurrence
  • Retrospective Studies
  • Uveitis, Anterior / complications
  • Uveitis, Anterior / diagnosis
  • Uveitis, Anterior / drug therapy
  • Uveitis, Anterior / immunology*

Substances

  • Biomarkers
  • HLA-B27 Antigen
  • Immunosuppressive Agents